|Bid||1.0300 x 3000|
|Ask||1.0800 x 1200|
|Day's range||0.9754 - 1.0900|
|52-week range||0.8200 - 9.7000|
|Beta (5Y monthly)||0.24|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Specalty medical-device maker PAVmed (NASDAQ: PAVM) didn't make for a great stock on Wednesday. PAVmed filed a shelf-registration statement with the Securities and Exchange Commission earlier in the day. In PAVmed's case, it's aiming to float $275 million worth of one or more of: common stock, preferred stock, warrants, debt securities, and units (i.e., a combination of at least two of the preceding types of securities).
Thursday was another great day for the stock market, although the Nasdaq Composite (NASDAQINDEX: ^IXIC) lagged behind some other major market benchmarks. Small-cap stocks don't always get as much attention as their larger counterparts, but they often have the best growth prospects. On Thursday morning, shares of Veritone (NASDAQ: VERI) and PAVmed (NASDAQ: PAVM) were among the top performers on the Nasdaq.
What happened Shares of PAVmed (NASDAQ: PAVM), a maker of tools for early detection of esophageal and pancreatic cancer, were down more than 15% as of 11:35 a.m. EDT today after the company reported earnings yesterday afternoon.